In early 2010, WHO recommended that every suspected malaria case be confirmed by microscopy or an RDT prior to treatment. In recent years, the availability of high-quality, inexpensive RDTs has made it possible to significantly improve and expand diagnostic testing across all levels of the health system, from district hospitals to community-based programmes.1
The SD BIOLINE Malaria rapid tests from Alere are the most preferred Malaria RDTs in the world. Based on the outstanding quality performance, SD BIOLINE Malaria Ag P.f. is the first test in the world to complete the WHO prequalification process, and the BinaxNOW® Malaria test is the first and only FDA-cleared Malaria RDT.